Renal impairment and all-cause mortality in cardiovascular disease: Effect modification by type 2 diabetes mellitus

European Journal of Clinical Investigation

Volumn 43, Issue 2, 2013, Pages 198-207

  Selvarajah, Sharmini ^a,b,c   Uiterwaal, Cuno S P M ^b   Haniff, Jamaiyah ^a   van der Graaf, Yolanda ^b,d   Visseren, Frank L J ^b,d   Bots, Michiel L ^b   Algra, Ale ^d   Doevendans, Pieter A ^d   Grobbee, Diederick E ^d   Jaap Kappelle, L ^d   Mali, Willem P Th M ^d   Moll, Frans L ^d   Rutten, Guy E H M ^d  

^a MINISTRY OF HEALTH   (Malaysia)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF MALAYA   (Malaysia)

^d NONE

Author keywords

Cardiovascular disease; Diabetes mellitus; Mortality; Renal impairment

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALBUMINURIA; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COHORT ANALYSIS; DIABETIC PATIENT; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEINURIA;

ADULT; AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY; RISK FACTORS;

EID: 84872608671     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12035     Document Type: Article

References (39)

1. Henry RMA, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine RJ et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney Int 2002;62:1402-7.
2. Mann JFE, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of Ramipril: the HOPE randomized trial. Ann Intern Med 2001;134:629-36.
3. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004;110:32-5.
4. Hillege HL, Fidler V, Diercks GFH, van Gilst WH, de Zeeuw D, van Veldhuisen DJ et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002;106:1777-82.
5. Gerstein HC, Mann JFE, Yi Q, Zinman B, Dinneen SF, Hoogwerf B et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286:421-6.
6. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004;15:1307-15.
7. Groop P-H, Thomas MC, Moran JL, Wadèn J, Thorn LM, Mäkinen V-P et al. The presence and severity of chronic kidney disease predicts all-cause mortality in Type 1 Diabetes. Diabetes 2009;58:1651-8.
8. Rossing P, Hougaard P, Borch-Johnsen K, Parving H-H. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ 1996;313:779-84.
9. Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Pagano G et al. Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetologia 2005;48:427-34.
10. Viazzi F, Leoncini G, Conti N, Tomolillo C, Giachero G, Vercelli M et al. Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients. J Hypertens 2010;28:848-55.
11. Gupta R, Birnbaum Y, Uretsky BF. The renal patient with coronary artery disease: current concepts and dilemmas. J Am Coll Cardiol 2004;44:1343-53.
12. Ani C, Ovbiagele B. Relation of baseline presence and severity of renal disease to long-term mortality in persons with known stroke. J Neurol Sci 2010;288:123-8.
13. Lin Y-S, Chiu F-C, Lin J-W, Hwang J-J, Caffrey JL. Association of albuminuria and cancer mortality. Cancer Epidemiol Biomarkers Prev 2010;19:2950-7.
14. Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM. Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. Kidney Int 2002;61:2165-75.
15. Cirillo M. Evaluation of glomerular filtration rate and of albuminuria/proteinuria. J Nephrol 2010;23:125-32.
16. Vaccaro O, Eberly LE, Neaton JD, Yang L, Riccardi G, Stamler J. for the Multiple Risk Factor Intervention Trial Research Group: impact of diabetes and previous myocardial infarction on long-term survival: 25-Year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial. Arch Intern Med 2004;164:1438-43.
17. Weitzman S, Wang C, Rosamond WD, Chambless LE, Cooper LS, Shahar E et al. Is diabetes an independent risk factor for mortality after myocardial infarction? The ARIC (Atherosclerosis Risk in Communities) Surveillance Study. Acta Diabetol 2004;41:77-83.
18. Eberly LE, Cohen JD, Prineas R, Yang L. Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality. Diabetes Care 2003;26:848-54.
19. Ahmed S, Cannon CP, Giugliano RP, Murphy SA, Morrow DA, Antman EM et al. The independent and combined risk of diabetes and non-endstage renal impairment in non-ST-segment elevation acute coronary syndromes. Int J Cardiol 2008;131:105-12.
20. Nabais S, Rocha S, Costa J, Marques J, Torres M, Magalhães S et al. Prognostic impact of moderate renal dysfunction in acute coronary syndromes. Rev Port Cardiol 2008;27:303-12.
21. Orchard T, Secrest A, Miller R, Costacou T. In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 2010;53:2312-9.
22. Simons PCG, Algra A, van de Laak MF, Grobbee DE, van der Graaf Y. Second Manifestations of ARTerial disease (SMART) study: rationale and design. Eur J Epidemiol 1999;15:773-81.
23. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, the Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130:461-70.
24. Ahlbom A, Alfredsson L. Interaction: a word with two meanings creates confusion. Eur J Epidemiol 2005;20:563-4.
25. Li R, Chambless L. Test for additive interaction in proportional hazards models. Ann Epidemiol 2007;17:227-36.
26. Andersson T, Alfredsson L, Källberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol 2005;20:575-9.
27. Janssen KJM, Donders ART, Harrell FE, Vergouwe Y, Chen Q, Grobbee DE et al. Missing covariate data in medical research: to impute is better than to ignore. J Clin Epidemiol 2010;63:721-7.
28. Knol MJ, Janssen KJM, Donders ART, Egberts ACG, Heerdink ER, Grobbee DE et al. Unpredictable bias when using the missing indicator method or complete case analysis for missing confounder values: an empirical example. J Clin Epidemiol 2010;63:728-36.
29. Weir MR. Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol 2007;2:581-90.
30. Hallan S, Astor B, Romundstad S, Aasarod K, Kvenild K, Coresh J. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: the HUNT II Study. Arch Intern Med 2007;167:2490-6.
31. Drury P, Ting R, Zannino D, Ehnholm C, Flack J, Whiting M et al. Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia 2011;54:32-43.
32. Coresh J. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010;375:2073-81.
33. Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S. Quinn RR et al. for the Alberta Kidney Disease Network: relation between kidney function, proteinuria, and adverse outcomes. JAMA 2010;303:423-9.
34. Glassock RJ. Estimated glomerular filtration rate: time for a performance review? Kidney Int 2009;75:1001-3.
35. Winearls CG, Glassock RJ. Dissecting and refining the staging of chronic kidney disease. Kidney Int 2009;75:1009-14.
36. Eknoyan G. Chronic kidney disease definition and classification: no need for a rush to judgment. Kidney Int 2009;75:1015-8.
37. Targher G, Zoppini G, Chonchol M, Negri C, Stoico V, Perrone F et al. Glomerular filtration rate, albuminuria and risk of cardiovascular and all-cause mortality in type 2 diabetic individuals. Nutr Metab Cardiovasc Dis 2010;210:575-80.
38. Soedamah-Muthu SS, Visseren FLJ, Algra A, Van Der Graaf Y. on behalf of the SSG: the impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study. Diabet Med 2008;25:51-7.
39. Kovesdy CP. Rate of kidney function decline associates with increased risk of death. J Am Soc Nephrol 2010;21:1814-6.